Stock listing
NASDAQ:REGN Regeneron Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Regeneron Pharmaceuticals, Inc.
Follow Regeneron Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:REGN
$927.89 USD +109.12 (+13.3%)
Close on Oct 30, 2026
- Day range
- $839.08 – $935.34 USDOct 30, 2026
- Volume
- 2.85M sharesOct 30, 2026
- Market cap
- $93.84B USDAt the close on Oct 30, 2026 · price × 101.1M shares outstanding
- 52-week range
- $591.52 – $935.34 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $597.9M USDMedian day 641,550 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:REGN · Home | $927.89 USD | +109.12 (+13.3%) | 2,851,725 | $869.43 | $935.34 | $839.08 | $818.77 | Close on Oct 30, 2026 |
| B3:REGN34 | 72.24 BRL | +5.32 (+7.9%) | 734 | 72.62 | 72.62 | 71.76 | 66.92 | Close on Oct 27, 2026 |
| Frankfurt:RGO | €826.40 EUR | +100.50 (+13.8%) | 11 | €738.30 | €826.40 | €738.30 | €725.90 | Close on Oct 30, 2026 |
| LSE:0R2M | $811.46 USD | +5.69 (+0.7%) | 198 | $816.99 | $816.99 | $797.51 | $805.77 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:REGN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $927.89 | +109.12 | +13.3% | $869.43 | $935.34 | $839.08 | 2,851,725 | |
| $818.77 | +5.50 | +0.7% | $826.14 | $828.19 | $811.63 | 781,724 | |
| $813.27 | -2.83 | -0.3% | $806.20 | $821.16 | $802.20 | 533,560 | |
| $816.10 | +8.43 | +1.0% | $807.67 | $816.14 | $804.17 | 716,874 | |
| $807.67 | +2.65 | +0.3% | $812.31 | $817.17 | $796.61 | 418,085 | |
| $805.02 | -14.07 | -1.7% | $819.09 | $819.09 | $801.22 | 527,718 | |
| $819.09 | +13.42 | +1.7% | $809.72 | $825.52 | $800.00 | 852,286 | |
| $805.67 | -1.81 | -0.2% | $806.74 | $813.86 | $800.24 | 578,415 | |
| $807.48 | +25.44 | +3.3% | $794.66 | $807.86 | $789.69 | 619,494 | |
| $782.04 | -8.70 | -1.1% | $792.59 | $800.00 | $780.83 | 489,437 | |
| $790.74 | -5.60 | -0.7% | $803.01 | $805.68 | $787.32 | 653,500 | |
| $796.34 | +17.98 | +2.3% | $802.33 | $809.49 | $792.58 | 798,800 | |
| $778.36 | +25.24 | +3.4% | $758.16 | $781.84 | $755.21 | 878,400 | |
| $753.12 | -9.69 | -1.3% | $762.49 | $765.60 | $743.57 | 629,600 | |
| $762.81 | +16.27 | +2.2% | $748.67 | $768.66 | $744.96 | 618,200 | |
| $746.54 | +6.97 | +0.9% | $737.20 | $751.27 | $732.83 | 466,000 | |
| $739.57 | -2.55 | -0.3% | $742.12 | $744.50 | $723.65 | 500,300 | |
| $742.12 | +3.40 | +0.5% | $738.05 | $753.68 | $734.18 | 626,400 | |
| $738.72 | +12.25 | +1.7% | $734.61 | $740.51 | $727.16 | 615,100 | |
| $726.47 | -8.73 | -1.2% | $734.37 | $736.42 | $722.02 | 694,700 | |
| $735.20 | +0.39 | +0.1% | $740.50 | $742.50 | $729.20 | 613,900 | |
| $734.81 | -23.46 | -3.1% | $766.53 | $777.43 | $726.02 | 1,042,800 | |
| $758.27 | +7.76 | +1.0% | $749.84 | $763.72 | $742.94 | 872,400 | |
| $750.51 | -1.74 | -0.2% | $745.85 | $752.47 | $741.83 | 804,300 | |
| $752.25 | -35.79 | -4.5% | $778.09 | $780.95 | $750.00 | 1,149,800 | |
| $788.04 | -7.98 | -1.0% | $803.87 | $803.87 | $784.13 | 592,100 | |
| $796.02 | -5.80 | -0.7% | $801.59 | $807.21 | $789.39 | 602,600 | |
| $801.82 | -2.08 | -0.3% | $805.23 | $813.53 | $790.02 | 721,100 | |
| $803.90 | +5.73 | +0.7% | $802.48 | $811.66 | $791.31 | 600,200 | |
| $798.17 | +13.32 | +1.7% | $786.03 | $801.44 | $779.96 | 704,400 | |
| $784.85 | -4.60 | -0.6% | $787.34 | $794.73 | $779.65 | 2,473,436 | |
| $789.45 | +14.84 | +1.9% | $781.18 | $789.99 | $774.78 | 702,816 | |
| $774.61 | +0.50 | +0.1% | $775.82 | $779.98 | $771.80 | 382,900 | |
| $774.11 | -19.63 | -2.5% | $788.53 | $788.58 | $769.57 | 540,600 | |
| $793.74 | +12.25 | +1.6% | $791.98 | $798.84 | $779.45 | 591,100 | |
| $781.49 | -11.77 | -1.5% | $800.00 | $800.22 | $780.81 | 444,000 | |
| $793.26 | -14.39 | -1.8% | $794.36 | $806.14 | $792.00 | 526,900 | |
| $807.65 | -2.66 | -0.3% | $803.83 | $808.63 | $796.73 | 621,400 | |
| $810.31 | -17.41 | -2.1% | $814.36 | $821.17 | $799.42 | 556,500 | |
| $827.72 | -15.75 | -1.9% | $840.06 | $841.54 | $825.83 | 561,100 | |
| $843.47 | -8.56 | -1.0% | $858.19 | $859.34 | $837.63 | 496,200 | |
| $852.03 | +28.21 | +3.4% | $826.24 | $854.49 | $825.77 | 749,400 | |
| $823.82 | +24.74 | +3.1% | $808.86 | $824.63 | $804.32 | 682,600 | |
| $799.08 | +4.89 | +0.6% | $782.44 | $802.78 | $779.08 | 894,100 | |
| $794.19 | -13.52 | -1.7% | $809.40 | $809.40 | $789.08 | 488,305 | |
| $807.71 | -7.08 | -0.9% | $806.18 | $817.62 | $804.27 | 766,800 | |
| $814.79 | -18.77 | -2.3% | $827.78 | $831.67 | $814.70 | 585,300 | |
| $833.56 | +5.06 | +0.6% | $829.22 | $839.94 | $823.44 | 505,400 | |
| $828.50 | -5.54 | -0.7% | $834.51 | $834.70 | $823.40 | 672,000 | |
| $834.04 | +7.40 | +0.9% | $835.74 | $847.00 | $826.64 | 786,800 | |
| $826.64 | -14.20 | -1.7% | $831.70 | $840.82 | $826.05 | 596,400 | |
| $840.84 | +30.60 | +3.8% | $817.17 | $844.92 | $815.38 | 750,400 | |
| $810.24 | +4.31 | +0.5% | $814.00 | $821.02 | $805.93 | 779,000 | |
| $805.93 | +2.45 | +0.3% | $801.76 | $813.18 | $795.73 | 541,300 | |
| $803.48 | -2.49 | -0.3% | $802.35 | $806.54 | $792.57 | 425,600 | |
| $805.97 | +7.98 | +1.0% | $802.21 | $815.80 | $794.49 | 709,700 | |
| $797.99 | +0.99 | +0.1% | $790.55 | $801.36 | $784.61 | 575,100 | |
| $797.00 | -11.05 | -1.4% | $808.80 | $813.63 | $796.66 | 939,100 | |
| $808.05 | +23.69 | +3.0% | $781.72 | $809.09 | $775.83 | 1,213,700 | |
| $784.36 | +12.25 | +1.6% | $774.47 | $785.99 | $767.17 | 837,600 | |
| $772.11 | +3.53 | +0.5% | $777.85 | $780.95 | $762.79 | 783,900 | |
| $768.58 | +7.92 | +1.0% | $767.98 | $782.59 | $763.31 | 532,400 | |
| $760.66 | +1.42 | +0.2% | $753.76 | $763.54 | $747.00 | 817,300 | |
| $759.24 | -3.39 | -0.4% | $769.54 | $772.75 | $756.44 | 842,600 | |
| $762.63 | +24.29 | +3.3% | $726.69 | $764.75 | $724.79 | 1,158,300 | |
| $738.34 | +42.92 | +6.2% | $701.90 | $740.00 | $694.98 | 1,460,700 |
- Ticker
- NASDAQ:REGN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Regeneron Reports Third Quarter 2026 Financial and Operating Results
Latest earnings call · Oct 30, 2026
Regeneron Pharmaceuticals (NASDAQ:REGN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 34 slides
Calls
Replays
Regeneron Pharmaceuticals (NASDAQ:REGN) Q3 2026 Earnings Call
Fri, Oct 30, 2026 · 8:30 AM ET
Watch TranscriptRegeneron Pharmaceuticals (NASDAQ:REGN) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 8:30 AM ET
Watch TranscriptRegeneron Pharmaceuticals (NASDAQ:REGN) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Regeneron Reports Third Quarter 2026 Financial and Operating Results
Oct 30, 2026
Closed $927.89 (+13.3%) on Oct 30, 2026
Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness
Oct 26, 2026
Closed $807.67 (+0.3%) on Oct 26, 2026
Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
Oct 25, 2026
Closed $807.67 (+0.3%) on Oct 26, 2026
Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types
Oct 16, 2026
Closed $790.74 (-0.7%) on Oct 16, 2026
Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026
Oct 6, 2026
Closed $738.72 (+1.7%) on Oct 6, 2026
Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)
Oct 1, 2026
Closed $734.81 (-3.1%) on Oct 1, 2026
Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
Oct 1, 2026
Closed $734.81 (-3.1%) on Oct 1, 2026
Upcoming Webinar Hosted by Xtalks: Inside Regeneron's Path to Scientific Intelligence and R&D Efficiency
Oct 1, 2026
Closed $734.81 (-3.1%) on Oct 1, 2026
Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies
Oct 1, 2026
Closed $734.81 (-3.1%) on Oct 1, 2026
Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026
Sep 24, 2026
Closed $788.04 (-1.0%) on Sep 25, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 34 slides · July 2026
Q1 2026 Earnings Presentation
Earnings · 36 slides · Apr 29, 2026
Investor Presentation (April 2026)
Investor deck · 40 slides · Apr 22, 2026
Technical Presentation (February 2026)
Technical · 19 slides · Feb 7, 2026
Regeneron Pharmaceuticals, Inc. on 6ix
- News releases
- 74 in the last 12 months · 371 in all · newest Oct 30, 2026 · oldest 2020
- Calls
- 32 calls with a replay · 32 with a transcript · latest Oct 30, 2026
- Decks
- 64 decks · latest July 2026
Where Regeneron Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:REGN · Home listing · This page | NASDAQ | United States | USD |
| gettex:RGO | gettex | Germany | EUR |
| LS Exchange:881535 | LS Exchange | Germany | EUR |
| Tradegate:RGO | Tradegate | Germany | EUR |
| BMV:REGN | BMV | Mexico | MXN |
| B3:REGN34 | B3 | Brazil | BRL |
| BOATS:REGN | BOATS | United States | USD |
| Frankfurt:RGO | Frankfurt | Germany | EUR |
| LSE:0R2M | LSE | United Kingdom | USD |
| Lang & Schwarz:881535 | Lang & Schwarz | Germany | EUR |
| Dusseldorf:RGO | Dusseldorf | Germany | EUR |
| VIE:REGN | Vienna | Austria | EUR |
| BIVA:REGN | BIVA | Mexico | MXN |
| Stuttgart:RGO | Stuttgart | Germany | EUR |
| Milan:1REGN | Milan | Italy | EUR |
| Munich:RGO | Munich | Germany | EUR |
| Turquoise:REGNN | Turquoise | United Kingdom | USD |
| Xetra:RGO | Xetra | Germany | EUR |
| EUROTLX:4REGN | EUROTLX | Italy | EUR |
| BX Swiss:RGO | BX Swiss | Switzerland | CHF |
| Hanover:RGO | Hanover | Germany | EUR |
| BVL:REGNUS | BVL | Peru | PEN |
| Hamburg:RGO | Hamburg | Germany | EUR |
Log in to ask 6ix AI your own questions about Regeneron Pharmaceuticals, Inc.